MATERIALS AND METHODS

Chemicals
+ -1S,3S,4R -and --1R,3R,4S -Menthols, and trans-p-menthane-3,8-diol were purchased from Tokyo Chemical Industry Co., Ltd. Tokyo, Japan . + -Menthofuran was purchased from Fluka Tokyo, Japan . NADP , glucose-6-phosphate, and glucose-6-phosphate dehydrogenase were purchased from Sigma-Aldrich St. Louise, MO, U.S.A. . Other reagents and chemicals used in this study were obtained from sources described previously or were of the highest quality commercially available 29 .
Enzymes and antibody
Human liver microsomal samples were obtained from Gentest Co., Inc. Woburn, MA, U.S.A. . Control serum, and mouse anti-human CYP2A6-specifi c monoclonal antibody and recombinant CYP1A1, 1A2, 2A6, 1B1, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4 expressed in Trichoplusia ni cells infected with a baculovirus containing cDNA encoding human P450 and NADPH-P450 reductase, were obtained from Gentest Co., Inc. The P450 content of these systems was used according to the manufacturer s instructions. All samples and enzymes were stored at 80 until use.
Oxidation of + -and --menthol enantiomers
by human liver microsomes and by human P450 enzymes Oxidation of + -and --menthols by liver microsomes was determined as follows. The standard reaction mixture contained liver microsomes 0.1 mg of proteins/mL or recombinant P450 100 pmol/mL , and 200 μM + -and --menthols in a fi nal volume of 0.50 mL in 100 mM potassium phosphate buffer pH 7.4 containing an NADPH-generating system 0.5 mM NADP , 5 mM glucose 6-phosphate, and 0.5 units of glucose 6-phosphate dehydrogenase/mL . Incubations were carried out at 37 for 60 min and terminated by the addition of 1.5 mL of dichloromethane. The mixtures were mixed vigorously and the extracts organic layer collected by centrifugation at 3,000 rpm for 5 min. The organic phase was transferred to an insert for identification of the metabolites by analysis with GC and GC-MS. The metabolic products were quantifi ed on the basis of the relative peak areas of GC.
Electron ionization mass spectral data analysis 70 eV was performed on a Hewlett-Packard model 5972 mass spectrometer connected to a Hewlett-Packard 5890 gas chromatograph Hewlett-Packard, Atlanta, GA , equipped with a split injector and a DB-5 silica capillary column 30 m length, 0.25 mm i. d. , using helium at 0.5 mL/min as the carrier gas. Analysis was performed as the follows: The column temperature was programmed from 60 to 240 at the rate of 4 /min and then held at 240 . The mass spectrometer was used in total ion chromatogram TIC mode and the m/z values were monitored as follows: at t R + -trans-pmenthane-3,8-diol . The retention time and mass spectral data of the enantiomer --menthol and its metabolite --trans-p-menthane-3,8-diol were identical to those of + -menthol and its metabolite, respectively.
Inhibition experiments
We evaluated the inhibitory effects of known P450 enzyme-selective inhibitors on the metabolism of + -and --menthols by human liver microsomes and recombinant P450 enzymes in order to identify which P450 enzymes were involved in each metabolic pathway. The inhibitors used in the present study were 2.5-10 μM + -menthofuran, a selective CYP2A6 inhibitor 30, 31 and 1-5 μL anti-CY-P2A6.
Correlation test and kinetic analysis
Correlation between contents of CYP2A6 and rates of + -and --menthol metabolite formations were compared in liver microsomes from 9 human samples.
Kinetic parameters for + -and --menthol metabolites formation by microsomes were estimated using a computer program designed for nonlinear regression analysis. Substrate concentrations used for the analysis of metabolism of + -and --menthols were 50, 100, 200, 400, and 600 μM.
RESULTS
Identification of + -and --menthol metabolites on
incubation with human liver microsomes + -1S,3S,4R and --1R,3R,4S -Menthol enantiomers were incubated with human liver microsomes in the presence of an NADPH-generating system and the products formed were analyzed by GC and GC-MS Fig. 1 . The mass spectrum data of + -and --menthol-derived metabolites are presented in Fig. 1A . The mass spectral data of metabolites from + -menthol are consist with the reference compound trans-pmenthane-3,8-diol . The mass data of metabolites from --menthol were identical to those obtained from + -menthol. The enantiomers of metabolites were identified by their retention time on the chiral column, CHROMPACK WCOT fused silica CP-Cyclodextrin-β-236-M-19 50 m length, 0.25 mm i.d. . On the basis of these data, it was concluded that the + -and --menthol enantiomers were oxidized to respective + -1S,3S,4S -and --1R,3R,4R -trans-p-menthane-3,8-diols by human liver microsomes.
Conversely, the reaction was not performed under conditions where + -and --menthols were incubated without microsomes data not shown .
Metabolism of + -and --menthols by recombinant
human P450 enzymes We examined the metabolism of + -and --menthols by recombinant systems containing 11 forms of human P450s and NADPH-P450 reductase expressed in T. ni cells. CY-P2A6 catalyzed the metabolism of + -and --menthols at signifi cant levels whereas all other forms of P450 including CYP1A1, CYP1A2, CYP1B1, CYP2B6, CYP2C8, CYP2C9, CYP2C19, CYP2D6, CYP2E1, and CYP3A4 were not active 3.3 Inhibition of + -and --menthols oxidation by human liver microsomes using + -menthofuran and anti-CYP2A6 + -Menthofuran, a known inhibitor of CYP2A6-dependent catalytic activity, signifi cantly inhibited metabolism of + -and --menthols by human liver microsomes. Anti-CYP2A6 slightly inhibited formation of + -and --menthols to + -and --trans-p-menthane-3,8-diols, respectively Fig. 3 .
Correlation between contents of CYP2A6 and rates
of + -and --menthol oxidation by human liver microsomes The above results indicate that CYP2A6 is an important enzyme in + -and --menthol oxidation by human liver microsomes. Correlation between the contents of CYP2A6 and rates of formations of + -and --trans-p-menthane-3,8-diols was examined in liver microsomes from 9 human samples. The mean level of CYP2A6 in the samples was estimated to be 12.5 10.2 pmol/mg protein 10.1 6.7 of total P450 . We found a good correlations between CY-P2A6 levels and formation of + -and --trans-p-menthane-3,8-diols r 0.91 and 0.81, respectively in these human samples Fig. 4 .
Kinetic analysis
Kinetic analysis of + -and --menthol oxidation activities were examined in human liver microsomes. The K m and V max values for the formation of + -and --trans-pmenthane-3,8-diols by human liver microsomes were 42 μM and 0.12 nmol/min/nmol P450, and 45 μM and 0.08 nmol/min/nmol P450, respectively. Kinetic analysis was 
DISCUSSION
The metabolism of + -1S,3S,4R and --1R,3R,4S -menthol enantiomers by human liver microsomal P450 enzymes was studied. The + -and --menthols were converted to + -1S,3S,4S -and --1R,3R,4R -trans-pmenthane-3,8-diols, respectively Fig. 5 . CYP2A6 was identifi ed as the enzyme involved in formation of + -and --trans p-menthane-3,8-diols by human liver microsomes based on the following evidence:Firstly, out of 11 recombinant human P450 enzymes tested, CYP2A6 catalyzed the oxidation of + -and --menthols; secondly, oxidation of + -and --menthols was inhibited by + -menthofuran and anti-CYP2A6 antibody; and fi nally, the activity of oxidation correlated with the content of CYP2A6 in liver microsomes of 9 human samples. Kinetic analysis showed that the enzyme efficiencies V max /K m ratio for + -and --trans-p-menthane-3,8-diols catalyzed by human liver microsomes were 2.81 and 1.77 ml/min/nmol protein, respectively. The + -and --menthol 8-hydroxylations were catalyzed by CYP2A6, and the V max /K m values were 368.9 and 195.9 nmol/min/nmol P450, respectively. Both V max /K m values were 1.5-and 2.0-fold higher for the + -menthol 8-hydroxylaton by human liver microsomes and recombinant CYP2A6 than those for --menthol. These results indicate that the substrate affi nity of + -menthol is higher than that of --menthol in human liver microsomes.
Various monoterpenoids, including menthol, have been reported to be biotransformed by several biocatalysts. We have previously shown that menthol is metabolized by S. litura to 7-hydroxymenthol and 6-hydroxymenthol, and by soil-borne plant pathogenic fungi R. solani to 6,8-dihydroxymenthol and 1-hydroxymenthol 10 12 . Additional studies have indicated that A. niger converts menthol to cis-p-menthane-7-ol, and limonene and thay Penicillium sp. converts menthol to p-cymene and γ-terpinene 13 .
Madhava et al. described the metabolism of menthol in rats 14 . Metabolism of --menthol has been studied extensively in experimental animal models using rats. The investigations on intact rats show that menthol is rapidly glucuronidated and excreted in urine and faces. In studies using bile duct-cannulated rats it was shown that biliary excretion is rapid and extensive, and that menthol undergoes an intensive enterohepatic circulation. After cleavage of the glucuronide and reabsorption in the small intestine, it is further metabolized in the liver. It was proposed that the fi rst step is hydroxylation at the C-8 position, followed by oxidation of the methyl group C-7 to a carboxylic group, and then hydroxylation at the C-9 position. p-Menthane-3, 8-diol and 3,8-dihydroxy-p-menthane-7-carboxylic acid were identifi ed as major metabolites not quantitated in the urine, and a fraction of these metabolites is excreted as glucuronides.
In this study, we found that CYP2A6 catalyzes the oxidation of + -and --menthols at signifi cant rates. This is in contrast with the results of studies in rats, which show menthol oxidation of C-8 position at high rates. Such species-related differences in the metabolism of xenobiotic chemicals by P450 enzymes are of interest to allow the extrapolation of biological and pharmacological data from experimental animals to humans.
In summary, the present results show that + -1S,3S,4R and --1R,3R,4S -menthol enantiomers were oxidized to their respective + -1S,3S,4S -and --1R,3R,4R -trans-p-menthane-3,8-diol derivatives in human liver microsomes. It is suggested that CYP2A6 is a principal enzyme in catalyzing + -and --menthol 8-hydroxylations in human liver microsomes. 
